Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $48.4600 (-0.84%) ($48.4600 - $48.4600) on Mon. Aug. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.65% (three month average) | RSI | 48 | Latest Price | $48.4600(-0.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Weekly Trend | HALO advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(40%) IWM(35%) IWO(35%) IWN(34%) SDY(34%) | Factors Impacting HALO price | HALO will decline at least -1.325% in a week (0% probabilities). VIXM(-13%) UUP(-8%) VXX(-6%) TBT(-5%) GLD(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.325% (StdDev 2.65%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $49.47 | 5 Day Moving Average | $50.13(-3.33%) | 10 Day Moving Average | $50.1(-3.27%) | 20 Day Moving Average | $49.47(-2.04%) | To recent high | -6.5% | To recent low | 29.7% | Market Cap | $6.623b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |